Truist is systematically divesting low-return, high-risk consumer loan portfolios (RAC and LightStream) to self-fund balance sheet de-risking and core franchise investments. At 9.0 times 2027 estimated EPS of $5.20, shares offer asymmetric upside toward our $55.00 price target.
Key points
- $5.20 estimated diluted EPS in 2027 and a 15.4% ROTCE reflect accelerating fixed-rate asset repricing, de-risked asset quality, and aggressive share repurchases.
- $1.85 billion in aggregate capital creation from exiting non-core auto (RAC) and unsecured consumer (LightStream) lending funds balance sheet restructuring and core franchise reinvestment.
- 16.9% upside to our $55.00 price target, supported by a 4.4% dividend yield, offers highly attractive risk-adjusted total return as execution risk recedes.
The call
At $47.07, the market prices Truist at 9.0 times 2027 earnings, implying that loan portfolio disposals will permanently dilute earnings capacity and cost inflation will outstrip efficiency gains. This valuation unduly penalizes Truist for post-merger integration delays, treating low-return divestitures as structural shrinkage rather than profitable balance sheet optimization.
Truist Diluted EPS Trend and Run-Rate Forecast ($ per share)- Reported & Adjusted Diluted EPS ($)
- Desk Forecast Run-Rate EPS ($)
Historical data from SEC filings and Q3 2026 earnings release; FY26E and FY27E reflect desk forecasts.
We believe the market is too pessimistic on Truist's operating transformation under new CEO Michael Lyons. Shedding RAC and LightStream lowers annual net charge-offs by 17 basis points, frees $1.85 billion in capital, and pays down high-cost wholesale funding. As fixed-rate assets reprice, 2027 earnings power reaches $5.20 per share.
12-Month Valuation Sensitivity by Forward P/E Multiple ($ per share)Desk scenario analysis based on 2027 estimated EPS of $5.20 and year-end 2026 TBVPS of $31.90.
Valuation
| Valuation Step | Metric / Multiple | Per Share Value |
|---|
| 2027 Estimated Diluted EPS | $5.20 | , |
| Target Forward Price-to-Earnings Multiple | 10.6x | $55.00 |
| Tangible Book Value per Share (End-2027E) | $34.88 | , |
| Implied Target Price-to-TBV Multiple | 1.58x | $55.00 |
| 12-Month Price Target | , | $55.00 |
Our 10.6 times forward P/E multiple sits below large-regional peer averages and aligns with 1.58 times projected 2027 tangible book value. As return on tangible common equity hits 15.4%, the multiple should re-rate toward peer parity. With 16.9% capital appreciation and a 4.4% cash dividend yield, asymmetry heavily favors a Buy.
Risks
- Reinvestment cost escalation across retail branches and treasury management systems eating into projected operating leverage.
- Protracted commercial loan paydowns delaying core loan volume recovery beyond early 2027.
- Re-acceleration of deposit competition pressuring total deposit costs above the guided 1.60% plateau.
What would change my mind
A deceleration in wholesale client deposit growth coupled with core commercial credit deterioration that forces higher credit loss provisions would invalidate our earnings ramp.